Search research articles
Contact Us
Filters
Showing results (521-530 of 626) with videos related to
Page
of 63
Sort By:
Journal of Viral Hepatitis
|
December 22, 1999
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study
M G Mutchnick, K L Lindsay, E R Schiff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2014
Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses
Lauren Byrd-Leotis, Renpeng Liu, Konrad C Bradley, et al.
Stroke
|
April 2, 2025
Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment
Heather J Fullerton, Nancy K Hills, Max Wintermark, et al.
Antiviral Research
|
June 15, 2011
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor
Olivia Goethals, Marcia Van Ginderen, Ann Vos, et al.
Molecular Microbiology
|
April 15, 2011
TP0326, a Treponema pallidum β-barrel assembly machinery A (BamA) orthologue and rare outer membrane protein
Daniel C Desrosiers, Arvind Anand, Amit Luthra, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2005
Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists
Pierre Raboisson, Juan José Marugán, Carsten Schubert, et al.
The FEBS Journal
|
July 1, 2025
Blood group O expression in normal tissues and tumors
Ea Kristine Clarisse Tulin, Lukas Muerner, Tanya R McKitrick, et al.
Seminars in Immunology
|
October 15, 2024
ABO blood groups and galectins: Implications in transfusion medicine and innate immunity
Connie M Arthur, Marie Hollenhorst, Shang-Chuen Wu, et al.
Journal of Medicinal Chemistry
|
January 23, 2014
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor
Åsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein
Dirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Page
of 63
Search research articles
Search
Showing results (521-530 of 626) with videos related to
Sort By:
Page
of 63
Journal of Viral Hepatitis
|
December 22, 1999
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study
M G Mutchnick, K L Lindsay, E R Schiff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2014
Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses
Lauren Byrd-Leotis, Renpeng Liu, Konrad C Bradley, et al.
Stroke
|
April 2, 2025
Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment
Heather J Fullerton, Nancy K Hills, Max Wintermark, et al.
Antiviral Research
|
June 15, 2011
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor
Olivia Goethals, Marcia Van Ginderen, Ann Vos, et al.
Molecular Microbiology
|
April 15, 2011
TP0326, a Treponema pallidum β-barrel assembly machinery A (BamA) orthologue and rare outer membrane protein
Daniel C Desrosiers, Arvind Anand, Amit Luthra, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2005
Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists
Pierre Raboisson, Juan José Marugán, Carsten Schubert, et al.
The FEBS Journal
|
July 1, 2025
Blood group O expression in normal tissues and tumors
Ea Kristine Clarisse Tulin, Lukas Muerner, Tanya R McKitrick, et al.
Seminars in Immunology
|
October 15, 2024
ABO blood groups and galectins: Implications in transfusion medicine and innate immunity
Connie M Arthur, Marie Hollenhorst, Shang-Chuen Wu, et al.
Journal of Medicinal Chemistry
|
January 23, 2014
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor
Åsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein
Dirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Page
of 63